Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Endometrial Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Endometrial Cancer Therapeuticsmarket, defines the market attractiveness level of Endometrial Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Endometrial Cancer Therapeutics industry, describes the types of Endometrial Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Endometrial Cancer Therapeutics market and the development prospects and opportunities of Endometrial Cancer Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Endometrial Cancer Therapeutics market in Chapter 13.
By Player:
F Hoffman La Roche Ltd
Bayer AG
Bristol-Myers Squibb Company
Merck KGaA
Takeda Pharmaceutical Company Limited
Novartis AG
Eli Lilly and Company
Sanofi
ArQule Inc
GlaxoSmithKline plc
By Type:
Chemotherapy
Hormone Therapy
Radiation Therapy
Surgery
By End-User:
Research Institutes
Hospitals & Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Endometrial Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Endometrial Cancer Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Endometrial Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Endometrial Cancer Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Endometrial Cancer Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.2 United States Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.3 Europe Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.4 China Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.5 Japan Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.6 India Endometrial Cancer Therapeutics Consumption (2017-2022)
-
7.7 South Korea Endometrial Cancer Therapeutics Consumption (2017-2022)
8 Region and Country-wise Endometrial Cancer Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Endometrial Cancer Therapeutics Consumption Forecast (2022-2028)
9 Global Endometrial Cancer Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Endometrial Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.2 Global Endometrial Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
10 Global Endometrial Cancer Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Endometrial Cancer Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Endometrial Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Endometrial Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Endometrial Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Endometrial Cancer Therapeutics Market Competitive Analysis
-
14.1 F Hoffman La Roche Ltd
-
14.1.1 F Hoffman La Roche Ltd Company Details
-
14.1.2 F Hoffman La Roche Ltd Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffman La Roche Ltd Endometrial Cancer Therapeutics Product and Service
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Details
-
14.2.2 Bayer AG Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer AG Endometrial Cancer Therapeutics Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Product and Service
-
14.4 Merck KGaA
-
14.4.1 Merck KGaA Company Details
-
14.4.2 Merck KGaA Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck KGaA Endometrial Cancer Therapeutics Product and Service
-
14.5 Takeda Pharmaceutical Company Limited
-
14.5.1 Takeda Pharmaceutical Company Limited Company Details
-
14.5.2 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Product and Service
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Details
-
14.6.2 Novartis AG Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis AG Endometrial Cancer Therapeutics Product and Service
-
14.7 Eli Lilly and Company
-
14.7.1 Eli Lilly and Company Company Details
-
14.7.2 Eli Lilly and Company Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly and Company Endometrial Cancer Therapeutics Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Endometrial Cancer Therapeutics Product and Service
-
14.9 ArQule Inc
-
14.9.1 ArQule Inc Company Details
-
14.9.2 ArQule Inc Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 ArQule Inc Endometrial Cancer Therapeutics Product and Service
-
14.10 GlaxoSmithKline plc
-
14.10.1 GlaxoSmithKline plc Company Details
-
14.10.2 GlaxoSmithKline plc Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline plc Endometrial Cancer Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Endometrial Cancer Therapeutics
-
Figure Endometrial Cancer Therapeutics Picture
-
Table Global Endometrial Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Endometrial Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Endometrial Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Endometrial Cancer Therapeutics Consumption by Country (2017-2022)
-
Figure United States Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Endometrial Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Endometrial Cancer Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Endometrial Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Endometrial Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Endometrial Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffman La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffman La Roche Ltd Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman La Roche Ltd Endometrial Cancer Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Endometrial Cancer Therapeutics Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Endometrial Cancer Therapeutics Product and Service
-
Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Endometrial Cancer Therapeutics Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Endometrial Cancer Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Endometrial Cancer Therapeutics Product and Service
-
Table ArQule Inc (Foundation Year, Company Profile and etc.)
-
Table ArQule Inc Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArQule Inc Endometrial Cancer Therapeutics Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Endometrial Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Endometrial Cancer Therapeutics Product and Service
-
